{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "TOT BIOPHARM-B", "longName": "TOT BIOPHARM International Company Limited", "messageBoardId": "finmb_642056462", "market": "hk_market", "marketState": "CLOSED", "earningsTimestamp": 1679582950, "earningsTimestampStart": 1679582950, "earningsTimestampEnd": 1679582950, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.1, "epsForward": -0.47, "sharesOutstanding": 772787968, "bookValue": 0.924, "fiftyDayAverage": 2.1436, "fiftyDayAverageChange": 0.5064001, "fiftyDayAverageChangePercent": 0.23623815, "twoHundredDayAverage": 2.4473, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": -3.6363602, "regularMarketPrice": 2.65, "regularMarketChange": -0.099999905, "regularMarketTime": 1683877565, "regularMarketDayHigh": 2.75, "regularMarketDayRange": "2.65 - 2.75", "regularMarketDayLow": 2.65, "regularMarketVolume": 132000, "regularMarketPreviousClose": 2.75, "bid": 2.6, "ask": 2.75, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 2.75, "averageDailyVolume3Month": 97301, "averageDailyVolume10Day": 122040, "fiftyTwoWeekLowChange": 0.9900001, "fiftyTwoWeekLowChangePercent": 0.59638566, "fiftyTwoWeekRange": "1.66 - 3.36", "fiftyTwoWeekHighChange": -0.7099998, "fiftyTwoWeekHighChangePercent": -0.21130948, "fiftyTwoWeekLow": 1.66, "fiftyTwoWeekHigh": 3.36, "twoHundredDayAverageChange": 0.20270014, "twoHundredDayAverageChangePercent": 0.082826026, "marketCap": 2047888128, "forwardPE": -5.638298, "priceToBook": 2.8679655, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "3.0 - Hold", "firstTradeDateMilliseconds": 1573176600000, "priceHint": 3, "symbol": "1875.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 120 Changyang Street", "address2": "Suzhou Industrial Park", "city": "Suzhou", "zip": "215024", "country": "China", "phone": "86 512 6296 5186", "fax": "86 512 6296 5286", "website": "https://www.totbiopharm.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TOT BIOPHARM International Company Limited, an investment holding company, engages in the research and development, manufacture, and marketing of anti-tumor drugs in the People's Republic of China. The company's principal drug candidate is TAB008 for the treatment of non-squamous non-small-cell lung cancer metastatic colorectal cancer, glioblastoma multiforme, ovarian cancer, cervical cancer, and hepatocellular carcinoma. It also offers TOZ309 for malignant brain tumor. Further, the company develops TAA013 for HER2+ breast cancer which is under Phase III clinical trial; TAE020 which is under preclinical trial for acute myeloid leukemia; TAB014 for wet age-related macular degeneration and is under Phase II clinical trial. In addition, it develops TAY018 for non-Hodgkin's lymphoma, myelodysplastic syndrome, acute myelogenous leukemia, and solid tumors; TAC020 for various solid tumors; TEP118 for biliary cancer, gallbladder tumors, metastatic cancer, non-small-cell lung cancer (NSCLC), and gastric cancer; TOM312 for cancer and HIV-associated cachexia; TIC318 for epithelial-derived ovarian cancer, small-cell lung cancer, head and neck squamous cell carcinoma, testicular tumors, malignant lymphoma, cervical cancer, bladder cancer, and NSCLC; TVP211 and TID214 for solid tumors; and TIO217 for gastrointestinal tumors. TOT BIOPHARM International Company Limited was incorporated in 2009 and is headquartered in Suzhou, the People's Republic of China.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Jun  Liu", "age": 54, "title": "CEO, Chief Scientific Officer & Exec. Director", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ben  Xiao", "age": 40, "title": "Sr. Fin. Director", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wing Yat  Lui", "age": 32, "title": "Joint Company Sec.", "yearBorn": 1990, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yifan  Chen", "age": 42, "title": "Joint Company Sec.", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}